Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; and Qinlock to treat gastrointestinal stromal tumors. It also develops Odronextamab to treat follicular …
Over the last 12 months, insiders at Zai Lab Limited have bought $126,690 and sold $2.92M worth of Zai Lab Limited stock.
On average, over the past 5 years, insiders at Zai Lab Limited have bought $222,127 and sold $60.45M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Smiley Joshua L (See Remarks) — $253,380.
The last purchase of 3,000 shares for transaction amount of $64,200 was made by Smiley Joshua L (See Remarks) on 2024‑05‑13.
2024-11-04 | Sale | Chief Financial Officer | 167 0.0002% | $30.66 | $5,121 | -9.40% | ||
2024-10-02 | Sale | Chief Financial Officer | 301 0.0003% | $25.40 | $7,645 | +7.46% | ||
2024-09-03 | Sale | director | 2,500 0.0025% | $19.50 | $48,750 | +36.23% | ||
2024-08-19 | Sale | Chief Legal Officer | 1,924 0.0019% | $16.95 | $32,620 | +54.09% | ||
2024-08-16 | Sale | See Remarks | 4,352 0.0045% | $16.67 | $72,561 | +1.90% | ||
2024-08-15 | Sale | Chief Financial Officer | 422 0.0004% | $16.06 | $6,779 | 0.00% | ||
2024-08-12 | Sale | See Remarks | 3,115 0.0031% | $16.20 | $50,463 | +60.88% | ||
2024-07-01 | Sale | Chairperson & CEO | 7,013 0.0069% | $17.48 | $122,573 | 0.00% | ||
2024-07-01 | Sale | director | 10,397 0.0102% | $17.32 | $180,085 | 0.00% | ||
2024-06-26 | Sale | Chairperson & CEO | 23,939 0.0242% | $17.90 | $428,532 | +37.76% | ||
2024-06-26 | Sale | See Remarks | 7,431 0.0075% | $17.90 | $133,022 | +37.76% | ||
2024-06-26 | Sale | Chief Legal Officer | 5,062 0.0051% | $17.90 | $90,615 | +37.76% | ||
2024-06-26 | Sale | Chief Financial Officer | 2,154 0.0022% | $17.90 | $38,559 | +37.76% | ||
2024-05-14 | Sale | Chief Legal Officer | 10,000 0.01% | $21.33 | $213,346 | -4.87% | ||
2024-05-13 | See Remarks | 3,000 0.003% | $21.40 | $64,200 | -4.46% | |||
2024-04-04 | Sale | See Remarks | 2,105 0.0022% | $15.67 | $32,992 | +29.00% | ||
2024-04-04 | Sale | See Remarks | 1,988 0.002% | $15.67 | $31,158 | +29.00% | ||
2024-04-04 | Sale | Chief Legal Officer | 1,244 0.0013% | $15.67 | $19,497 | +29.00% | ||
2024-04-04 | Sale | See Remarks | 1,952 0.002% | $15.67 | $30,594 | +29.00% | ||
2024-04-04 | Sale | Chief Financial Officer | 845 0.0009% | $15.67 | $13,244 | +29.00% |
Smiley Joshua L | See Remarks | 43232 0.0397% | $26.89 | 4 | 2 | |
WIRTH PETER | director | 0 0% | $26.89 | 1 | 1 | <0.0001% |
Wellington Management Company | $106.66M | 6.68 | 6.66M | +24.76% | +$21.17M | 0.02 | |
Capital World Investors | $91.06M | 5.71 | 5.68M | +8.92% | +$7.45M | 0.02 | |
Janus Henderson | $70.92M | 4.45 | 4.43M | +9.6% | +$6.21M | 0.04 | |
Woodline Partners LP | $41.6M | 2.61 | 2.6M | +28.65% | +$9.26M | 0.36 | |
Viking Global Investors | $32.81M | 2.06 | 2.05M | +9.57% | +$2.87M | 0.01 |